The treatment of Dercum disease typically involves symptom management as there is currently no cure. Non-invasive treatment options, like analgesics, are usually recommended in individuals with more generalized forms of Dercum disease. Paracetamol (i.e., acetaminophen), a non-opioid analgesic medication, can be used for mild to moderate pain. Even though Dercum disease appears to be resistant to non-steroidal anti-inflammatory drugs (NSAIDS) as no active inflammation is identified in the condition, some researchers report that they may also be effective in reducing pain. Pregabalin, typically used to treat neuropathic pain, has also been shown to be effective in managing Dercum disease. Recently, deoxycholic acid, an injectable medication, was suggested, which naturally breaks down and absorbs fat. This method seems to be highly effective in reducing existing lipomas, yet its effectiveness on Dercum disease needs further investigation. Another experimental treatment option that was reported to reduce symptoms is transcutaneous frequency rhythmic electrical stimulation of the fatty tissue, which seems to be effective and safe when applied to individuals with Dercum disease.
The most predominant methods suggested by healthcare professionals are liposuction and topical lidocaine application in the sites of pain. Liposuction is the most common method of management proposed in the literature. Though liposuction is typically utilized for general removal of fat tissue, in the setting of Dercum disease, liposuction is used to target the lipomas. By reducing the fat deposits and destroying some nerve plexuses within the adipose tissue, pain relief can usually be achieved. Unfortunately, while the pain can be diminished for an extended period of time (i.e., about five years), after liposuction, it may reoccur. Additionally, surgical removal of the lipomas or large parts of the skin with subcutaneous fat has also been suggested. Lidocaine injection of lesions may also be effective for some individuals; however, it offers only short-term pain relief (i.e., from 2 to 12 months).